[EN] IDOL DERIVATIVES AS NEW THYROID RECEPTOR AGONIST LIGANDS AND METHODS<br/>[FR] DERIVES D'INDOL UTILISES COMME NOUVEAUX LIGANDS AGONISTES DU RECEPTEUR DE LA THYROIDE
申请人:KAROBIO AB
公开号:WO2004018421A1
公开(公告)日:2004-03-04
This invention relates to novel compounds of the general formula (I), which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor Beta and to methods of preparing such compound. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolism dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described herein is administered in a therapeutically effective amount.
本发明涉及一般式(I)的新化合物,这些化合物是甲状腺受体配体,且优选选择性作用于甲状腺激素受体Beta,并提供了制备这种化合物的方法。此外,提供了一种用于预防、抑制或治疗与代谢功能紊乱有关或依赖于T3调控基因表达的疾病或疾病的方法,其中根据本文所述的化合物以治疗有效剂量的方式给予。